PYCR1 was validated as a significant SNSCC marker through RT-qPCR, and its high expression correlated with poor overall patient survival, suggesting PYCR1 could serve as a tumor-associated prognostic biomarker for SNSCC. Here, PYCR1 is linked to neoplasm.